Estados Unidos · Plataformas y datos · Morningstar

What Should The Chemours Company Investors Know After 18.63% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline

Publicado por Morningstar · Estados Unidos hace 10 h

On August 4, 2026, Chemours announced second quarter 2026 financial results. Among other things, the Company reduced its adjusted EBITDA full-year guidance to $775 million to $825…

Leer el artículo completo en Morningstar Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.morningstar.com)

What Should The Chemours Company Investors Know After 18.63% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline

También te puede interesar

Grab (NASDAQ:GRAB) Stock: Insider Philipp Wolfgang Josef Kandal Sells 30,000 Shares

SpaceX Q3 earnings: Revenue seen surging to $13B as AI business takes centre stage

Up 10% in the Last Two Weeks, Is Airbnb the Perfect Stock for Today's Market?

Three big takeaways from the IMF-World Bank meetings

Gold dips as oil prices fuel inflation fears, Fed outlook in focus

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.

What Should The Chemours Company Investors Know After 18.63% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline

Compartir

También te puede interesar

Grab (NASDAQ:GRAB) Stock: Insider Philipp Wolfgang Josef Kandal Sells 30,000 Shares

SpaceX Q3 earnings: Revenue seen surging to $13B as AI business takes centre stage

Up 10% in the Last Two Weeks, Is Airbnb the Perfect Stock for Today's Market?

Three big takeaways from the IMF-World Bank meetings

Gold dips as oil prices fuel inflation fears, Fed outlook in focus

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.